Skip to main content

RxVP Leadership

Built by leaders

Meet The Founders

Bonnie Lappin

CREATOR, CO-FOUNDER, AND BUILDER OF THE HEALTHCARE BUSINESSWOMEN'S AMBASSADOR PROGRAM
Country Lead
Flag
USA
Bonnie Lappin is an esteemed leader known for her dedication to fostering professional growth and innovation. Her career reflects a profound commitment to empowering individuals and shaping organizations to achieve exceptional results.

Bonnie co-founded and built the Healthcare Businesswomen's Ambassador Program (HBA), the signature leadership development program of HBA – a global non-profit organization with 20,000 members and 140 corporate partners. The Ambassador Program has engaged over 11,000 participants worldwide to date.

She has served on HBA boards in Boston, Europe, and Florida and co-founded the HBA Miami chapter.

Since 1990, Bonnie has also served as President of The Lappin Company, specializing in executive search and career consulting. Her leadership impact spans globally, having spoken on leadership and career development in the U.S., Switzerland, India, Malaysia, Japan, France, UK, Germany, Singapore, and Ireland.

Bonnie has mentored hundreds of professionals worldwide and is internationally recognized for advancing leadership in the life sciences industry. She was awarded the PharmaVOICE 100 Award in 2017 and is the sole recipient of the HBA Visionary Leader Award.

Suzette DiMascio

CREATOR, CO-FOUNDER, AND Executive Healthcare Strategist
Country Lead
Flag
USA
Recognized internationally as a trusted advisor, innovator, investor, media contributor, and sought-after keynote speaker, Suzette possesses a relentless drive to transform patient care - teamed with a keen ability to assess and assimilate ideas to drive financial success aligned with corporate culture and business growth.

As the founder and former CEO of CSI Specialty Group, Suzette built one of the industry's top-ranked consulting firms, guiding Fortune 500 manufacturers, integrated delivery networks (IDNs), and private equity-backed ventures through complex challenges in commercialization, workforce planning, digital health, and market access. Under her leadership, CSI received national recognition from Consulting Magazine, Goldman Sachs, and The Commonwealth Institute for rapid growth and industry innovation.

Suzette is also a passionate patient advocate. She launched the industry's first specialty pharmacy podcast, was inducted into the APPA Hall of Fame, and has served in appointed leadership roles, including the Florida State Board of Employee Leasing and Florida's Talent Caucus. She is a Founding Member and past Board Director for the National Association of Specialty Pharmacy (NASP), Past Global Director of HMA's Ambassador Program, and serves on several industry advisory boards.

Today, she brings her entrepreneurial mindset to a Fortune 15 company, helping to shape strategy across the Evernorth and Cigna ecosystem to further enhance patient care. Whether advising the C-suite, mentoring future leaders, or reimagining patient access models, Suzette leads with integrity, vision, and a relentless commitment to making healthcare better for everyone
background pattern
RxVP Asia Pacific

Asia Pacific: Shaping the Future of Life Sciences Leadership

Leadership in Asia Pacific

Dr. Deepa Desai

Dr. Deepa Desai

RxVP Head of Asia Pacific, Mumbai

RxVP Asia Pacific is led by Dr. Deepa Desai, based in Mumbai, whose career spans more than two decades of global healthcare leadership.

She has held senior executive roles at IQVIA and LabCorp, leading global teams of more than 5,000 professionals across complex, multi market environments.

She is also the founder of one of India’s first Healthcare Leadership Summits, 2024, convening leaders from over 25 organizations to advance executive collaboration.

Her appointment reflects RxVP’s commitment to ensuring Asia Pacific is not only represented on the global stage, but actively shaping it.

From regional strength to global influence, Asia Pacific leaders are defining the next era of Life Sciences.

Why Asia Pacific, Now?

Asia Pacific has become one of the most strategically significant regions in global Life Sciences.

India, in particular, has emerged as a major innovation and capability hub, with nearly 80% of the world’s top 15 pharmaceutical companies establishing Global Capability Centers, GCCs, in the country. Across the region, investment, talent density, and executive influence continue to accelerate.

This is no longer a region contributing at the margins, it is helping shape global strategy.

With growth comes the need for deeper leadership connection and trusted platforms for peer exchange.

RxVP Asia Pacific meets this moment, fostering dialogue, strengthening collaboration, and ensuring the region plays an active role in shaping the future of Life Sciences.